Daxor Corporation (DXR) Key Metrics
DXR valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $58.7M
- Enterprise value
- $42.9M
- P/E (TTM)
- 9.1 10-yr median 18.4
- Forward P/E
- 64.5
- PEG ratio
- —
- Price / sales
- — 10-yr median 14.8
- Price / book
- 1.2 10-yr median 2.1
- EV / EBITDA
- — 10-yr median 16.8
- Dividend yield
- —
- Beta
- 0.35
DXR key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsDXR valuation Price multiples at each fiscal year-end price.
DXR returns How much profit the business earns on the capital it uses.
DXR per-share figures Results divided by the shares outstanding at year-end.
DXR financial health Debt, liquidity and how easily interest is covered.
DXR efficiency & capital use Working capital cycle and where the cash goes.
DXR valuation history
DXR returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
DXR debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
DXR cash returned to shareholders
DXR price vs earnings per share
DXR key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $73.5M | $37.2M | $44.5M | $78.6M | $45.6M | $49.2M | $39.4M | $30.7M | $17.2M | $31.5M |
| Enterprise value | $73.6M | $38.0M | $45.2M | $79.8M | $47.9M | $48.8M | $40.7M | $35.1M | $20.5M | $32.1M |
| P/E ratio | 8.0 | 69.4 | 158.4 | 15.2 | 9.6 | — | — | — | — | 21.7 |
| Price / sales | 146.1 | 17.5 | 1.3 | 12.5 | 7.8 | — | — | — | — | 17.2 |
| Price / book | 1.6 | 1.0 | 1.3 | 2.7 | 2.2 | 3.1 | 3.1 | 2.3 | 1.3 | 2.1 |
| Price / free cash flow | — | — | — | — | — | — | 12.6 | — | — | 19.8 |
| Price / operating cash flow | — | — | — | — | — | — | 12.6 | — | — | 19.8 |
| EV / sales | 146.3 | 17.8 | 1.3 | 12.7 | 8.2 | — | — | — | — | 17.5 |
| EV / EBITDA | 8.0 | 18.4 | 40.5 | 15.2 | 10.1 | — | — | — | — | 21.9 |
| EV / free cash flow | — | — | — | — | — | — | 13.1 | — | — | 20.2 |
| Earnings yield | 12.5% | 1.4% | 0.6% | 6.6% | 10.4% | −3.5% | −1.3% | −2.9% | −7.2% | 4.6% |
| Free cash flow yield | −0.8% | 0.1% | −8.2% | −1.0% | −6.1% | −5.0% | 7.9% | −4.3% | −6.8% | 5.1% |
| Dividend yield | — | — | — | — | — | — | — | — | 0.7% | 0.4% |
| Shareholder yield (dividends + buybacks) | — | — | 0.9% | — | — | 0.0% | — | 0.1% | 2.1% | 1.7% |
| Share price at fiscal year-end | $14.75 | $7.69 | $9.60 | $9.16 | $11.29 | $12.50 | $9.40 | $8.20 | $4.57 | $8.24 |
| Per share | ||||||||||
| Revenue per share | $0.10 | $0.44 | $7.47 | $0.74 | $1.44 | $0.00 | $0.00 | $0.00 | $0.00 | $0.48 |
| Earnings per share | $1.84 | $0.11 | $0.06 | $0.60 | $1.18 | −$0.43 | −$0.12 | −$0.24 | −$0.33 | $0.38 |
| Operating cash flow per share | −$0.12 | $0.01 | −$0.79 | −$0.09 | −$0.68 | −$0.62 | $0.74 | −$0.35 | −$0.31 | $0.42 |
| Free cash flow per share | −$0.12 | $0.01 | −$0.79 | −$0.09 | −$0.68 | −$0.62 | $0.74 | −$0.35 | −$0.31 | $0.42 |
| Cash per share | — | — | — | — | $0.18 | $0.16 | — | — | $0.29 | $0.57 |
| Book value per share | $9.20 | $7.39 | $7.34 | $3.38 | $5.24 | $3.98 | $3.05 | $3.49 | $3.65 | $4.01 |
| Tangible book value per share | $9.20 | $7.39 | $7.34 | $3.38 | $5.24 | $3.98 | $3.05 | $3.49 | $3.65 | $4.01 |
| Dividends per share | — | — | — | — | — | — | — | — | $0.03 | $0.03 |
| Capex per share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Debt per share | $0.02 | $0.15 | $0.16 | $0.14 | $0.75 | $0.04 | $0.32 | $1.19 | $1.15 | $0.73 |
| Shares outstanding | 5.0M | 4.8M | 4.6M | 8.6M | 4.0M | 3.9M | 4.2M | 3.7M | 3.8M | 3.8M |
| Change in shares outstanding | +2.9% | +4.6% | −46.0% | +112.6% | +2.6% | −6.0% | +11.9% | −0.7% | −1.5% | −0.5% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | 22.5% | 1.5% | 0.9% | 20.7% | 25.8% | −12.0% | −3.8% | −6.6% | −8.5% | 9.8% |
| Return on invested capital (ROIC) | 17.6% | 1.4% | 1.0% | 19.6% | 24.5% | −9.3% | −2.5% | −5.0% | −5.5% | 9.2% |
| Return on assets (ROA) | 22.2% | 1.5% | 0.9% | 18.7% | 22.9% | −11.1% | −3.1% | −4.8% | −6.2% | 7.0% |
| Return on tangible assets | 19.9% | 1.5% | 0.8% | 17.1% | 19.0% | −10.3% | −3.5% | −5.0% | −6.4% | 7.1% |
| Free cash flow margin | −120.1% | 1.2% | −10.6% | −12.2% | −47.4% | — | — | — | — | 86.8% |
| Income quality (OCF / net income) | −0.07 | 0.05 | −13.02 | −0.15 | −0.58 | — | — | — | — | 1.09 |
| Financial health | ||||||||||
| Total debt | $112,000 | $729,966 | $755,659 | $1.2M | $3.0M | $170,689 | $1.3M | $4.5M | $4.3M | $2.8M |
| Cash & short-term investments | — | — | — | — | $710,700 | $617,800 | — | — | $1.1M | $2.2M |
| Net debt | $112,000 | $729,966 | $755,659 | $1.2M | $2.3M | −$447,111 | $1.3M | $4.5M | $3.2M | $617,866 |
| Debt / equity | 0.00 | 0.02 | 0.02 | 0.04 | 0.14 | 0.01 | 0.11 | 0.34 | 0.32 | 0.18 |
| Debt / assets | 0.00 | 0.02 | 0.02 | 0.04 | 0.12 | 0.01 | 0.09 | 0.25 | 0.22 | 0.14 |
| Net debt / EBITDA | 0.01 | 0.35 | 0.68 | 0.23 | 0.49 | — | — | — | — | 0.42 |
| Current ratio | — | 0.17 | 0.25 | 0.61 | 0.95 | 0.04 | 0.42 | 0.51 | 0.60 | 335.00 |
| Quick ratio | — | 0.17 | 0.25 | 0.61 | 0.95 | 0.04 | 0.42 | 0.51 | 0.60 | 335.00 |
| Interest coverage | 575.4 | 7.3 | 6.7 | 72.5 | 242.2 | -206.0 | -3.5 | -9.0 | -15.7 | 39.3 |
| Working capital | — | −$91,762 | −$77,217 | −$24,597 | −$41,928 | −$677,702 | −$46,012 | −$35,776 | −$29,731 | $2.6M |
| Invested capital | $46.0M | $36.5M | $34.8M | $30.2M | $23.5M | $15.2M | $14.1M | $17.5M | $17.0M | $16.0M |
| Tangible asset value | $45.9M | $35.8M | $34.0M | $29.0M | $21.2M | $15.7M | $12.8M | $13.1M | $13.8M | $15.3M |
| Net current asset value | — | −$821,728 | −$832,876 | −$1.3M | −$3.1M | −$848,391 | −$1.4M | −$4.5M | −$5.5M | −$2.7M |
| Graham number | $19.52 | $4.29 | $3.16 | $6.77 | $11.78 | — | — | — | — | $5.86 |
| Graham net-net per share | −$0.02 | −$0.17 | −$0.18 | −$0.15 | −$0.77 | −$0.06 | −$0.34 | −$1.21 | −$1.18 | −$0.80 |
| Capital allocation | ||||||||||
| Dividends paid | — | — | — | — | — | — | — | — | $112,102 | $113,989 |
| Share buybacks (net) | — | — | $401,266 | — | — | $0 | — | $32,222 | $248,203 | $435,322 |
| Dividend payout ratio | — | — | — | — | — | — | — | — | — | 7.8% |
| Dividends + buybacks / free cash flow | — | — | — | — | — | — | — | — | — | 34.5% |
| Capex / revenue | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — | — | — | 0.0% |
| Capex / operating cash flow | — | 0.0% | — | — | — | — | 0.0% | — | — | 0.0% |
| Capex / depreciation | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — |
| Stock-based compensation / revenue | — | 58.5% | 1.8% | 12.5% | 12.5% | — | — | — | — | 0.6% |
| R&D / revenue | — | — | 0.0% | 0.0% | 0.0% | — | — | — | — | — |
| SG&A / revenue | 65.0% | 13.8% | 2.7% | 17.2% | 17.0% | — | — | — | — | 16.6% |
| Efficiency | ||||||||||
| Days sales outstanding | — | 2.0 | 0.2 | 1.4 | 1.9 | — | — | — | — | 7.9 |
| Days payables outstanding | 128.9 | — | 170.6 | 25.2 | 30.5 | 51.5 | 56.5 | 77.7 | 77.9 | 11.2 |
| Cash conversion cycle (days) | — | — | -170.4 | -23.8 | -28.6 | — | — | — | — | -3.3 |
| Receivables turnover | — | 178.50 | 2,201.03 | 263.30 | 194.05 | 0.00 | 0.00 | 0.00 | 0.00 | 46.31 |
| Payables turnover | 2.83 | 0.00 | 2.14 | 14.51 | 11.97 | 7.09 | 6.46 | 4.70 | 4.68 | 32.64 |
| Asset turnover | 0.01 | 0.06 | 1.06 | 0.23 | 0.28 | 0.00 | 0.00 | 0.00 | 0.00 | 0.09 |
| Average receivables | — | $11,938 | $15,716 | $23,966 | $29,999 | $31,018 | $33,224 | $39,490 | $45,571 | $39,628 |
| Average payables | $111,165 | $106,714 | $82,768 | $74,918 | $83,700 | $79,375 | $75,625 | $73,750 | $41,409 | $8,478 |
| Intangibles / total assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Computed from DXR's annual financial statements (latest annual report filed December 31, 2025) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
DXR valuation and financial ratios
At the end of fiscal 2025 (December 31, 2025), Daxor traded at 8.0 times earnings, against a 10-year median of 18.4. Based on the latest twelve months, the trailing P/E is 9.1 and the forward P/E is 64.5. Daxor earned a return on equity of 22.5% and a return on invested capital of 17.6% in fiscal 2025. It ended the year with $0.1 million of debt and no reported cash in cash and short-term investments, net debt of $0.1 million. The share count rose 30.3% from 3.8M to 5.0M over 9 years.
See the DXR income statement, the DXR chart for price history, or the DXR stock overview for the latest quote and news.
DXR key metrics FAQ
What is Daxor's P/E ratio?
Daxor's trailing P/E ratio is 9.1 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 64.5. At the end of fiscal 2025 it was 8.0, compared with a 10-year median of 18.4.
What is Daxor's EV/EBITDA?
Daxor's enterprise value was 8.0 times EBITDA at the end of fiscal 2025 (enterprise value $73.6 million, EBITDA $9.2 million).
What is Daxor's return on equity?
Daxor's return on equity (ROE) was 22.5% in fiscal 2025: net income of $9.2 million on average shareholders' equity of $40.8 million.
What is Daxor's ROIC?
Daxor's return on invested capital was 17.6% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Daxor have?
Daxor had total debt of $0.1 million at the end of fiscal 2025, a debt-to-equity ratio of 0.00 and $0.1 million of net debt (0.01 times EBITDA).
What is Daxor's free cash flow yield?
Daxor generated -$0.6 million of free cash flow in fiscal 2025, a free cash flow yield of −0.8% on its market value at year-end ($73.5 million).